Authors

• Robert Landewé (ORCID: https://orcid.org/0000-0002-0577-6620)
• Jeffrey R. Curtis (ORCID: https://orcid.org/0000-0002-8907-8976)
• Servet Akar (ORCID: https://orcid.org/0000-0002-3734-1242)
• Marina Magrey (ORCID: https://orcid.org/0000-0002-6520-5619)
• Cunshan Wang
• Solomon B. Makgoeng
• Dona Fleishaker
• Atul Deodhar (ORCID: https://orcid.org/0000-0002-2130-1246)
• Arne Yndestad (ORCID: https://orcid.org/0000-0003-0855-1379)
• Bassel Elzorkany (ORCID: https://orcid.org/0000-0003-2704-9712)
• Lara Fallon (ORCID: https://orcid.org/0000-0001-7113-1014)
• Ivana Vranić (ORCID: https://orcid.org/0000-0002-2990-4914)
• Joseph Wu (ORCID: https://orcid.org/0009-0006-3464-2556)
• Annette Diehl
• Sujatha Menon

Institutions

• Cairo University (EG)
• Oregon Health & Science University (US)
• Pfizer (United States) (US)
• Pfizer (United Kingdom) (GB)
• Izmir Kâtip Çelebi University (TR)
• University of Alabama at Birmingham (US)
• Zuyderland Medisch Centrum (NL)
• Amsterdam University Medical Centers (NL)
• Pfizer (Canada) (CA)
• Case Western Reserve University (US)

Publication Details

Journal

Advances in Rheumatology

Published

2024-12-18

DOI

https://doi.org/10.1186/s42358-024-00402-x

Citations

4

Primary Topic

Spondyloarthritis Studies and Treatments

Type

article

Field-Weighted Citation Impact

1.88

Funders

• Pfizer